The outlook of companies tied to blockbuster drugs like Viagra presents a challenging investment scenario . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the patent expiration in key regions has introduced substantial volatility. Investors are now facing the effect of rival medicat